• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

C5G:GR

13.595 EUR 0.290 2.09%

As of 02:08:24 ET on 10/02/2014.

Snapshot for Orexo AB (C5G)

Open: 13.595 Day's Range: 13.595 - 13.595 Volume: 0
Previous Close: 13.885 52wk Range: 10.105 - 20.280 1-Yr Rtn: -5.29%

Stock Chart for C5G

No chart data available.
  • C5G:GR 13.595
  • 1M
  • 1Y
13.885
Interactive C5G Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for C5G

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) -2.0970
Est. PEG Ratio -
Market Cap (M EUR) 466.65
Shares Outstanding (M) 34.33
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for C5G

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for C5G

Orexo AB is a product oriented drug delivery company that develops new pharmaceuticals by further develop existing products. The Company specializes in drugs in tablet form especially sublingual pills and often works together with scientists and other corporations. Orexo sells internationally.

Martin NicklassonChairmanNikolaj SoerensenChief Executive Officer
Jesper LindChief Operating OfficerPeter EdmanChief Scientific Officer
More Company Profile & Key Executives for C5G

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil